Who owns Igm Biosciences Inc Com?
- Ticker: IGMS
- CUSIP Number: 449585108
Tip: Access positions for across all investors
Analyze quarterly positions in Igm Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Igm Biosciences stock
Who bought or sold Igm Biosciences Inc Com this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Baker Bros. Advisors | 3.7M | $31M | 17% | Dec 2023 |
|
T. Rowe Price Associates | 3.3M | $27M | 1% | Dec 2023 |
|
Artal Group | 3.1M | $26M | 23% | Dec 2023 |
|
Redmile Group | 3.0M | $25M | 0% | Dec 2023 |
|
FMR | 2.1M | $18M | 0% | Sep 2023 |
|
Goldman Sachs Group | 1.0M | $8.6M | 128% | Dec 2023 |
|
RA Capital Management | 938k | $7.8M | 0% | Dec 2023 |
|
Vanguard Group | 897k | $7.5M | 0% | Dec 2023 |
|
BlackRock | 871k | $7.3M | 2% | Sep 2023 |
|
ExodusPoint Capital Management | 454k | $3.8M | 100% | Sep 2023 |
|
Geode Capital Management | 293k | $2.4M | 33% | Sep 2023 |
|
State Street Corporation | 289k | $2.4M | 11% | Sep 2023 |
|
Millennium Management | 247k | $2.1M | -68% | Dec 2023 |
|
Citadel Advisors | 226k | $1.9M | 610% | Dec 2023 |
|
Rhenman & Partners Asset Management AB | 200k | $1.7M | 0% | Sep 2023 |
|
First Manhattan | 172k | $1.4M | 100% | Sep 2023 |
|
Samsara BioCapital | 155k | $1.3M | 0% | Dec 2023 |
|
Northern Trust | 136k | $1.1M | 12% | Sep 2023 |
|
Exome Asset Management | 136k | $1.1M | 100% | Dec 2023 |
|
Hudson Bay Capital Management | 124k | $1.0M | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 121k | $1.0M | 21% | Dec 2023 |
|
Renaissance Technologies | 91k | $759k | -48% | Sep 2023 |
|
TD Asset Management | 84k | $694k | 0% | Dec 2023 |
|
Nuveen Asset Management | 79k | $661k | 0% | Sep 2023 |
|
Woodline Partners | 75k | $626k | 0% | Sep 2023 |
|
Morgan Stanley | 74k | $616k | -26% | Sep 2023 |
|
Bruce & Co | 65k | $540k | -46% | Dec 2023 |
|
Bank of New York Mellon | 52k | $432k | 0% | Dec 2023 |
|
Manufacturers Life Insurance Company | 49k | $409k | 0% | Sep 2023 |
|
D. E. Shaw & Co | 47k | $393k | -38% | Dec 2023 |
|
Eagle Bay Advisors | 45k | $371k | 0% | Dec 2023 |
|
Dimensional Fund Advisors | 40k | $328k | -2% | Dec 2023 |
|
Springbok Capital Management | 37k | $311k | 89% | Sep 2023 |
|
Putnam Investments | 37k | $305k | 25% | Sep 2023 |
|
Jane Street | 36k | $296k | 100% | Dec 2023 |
|
Alliancebernstein | 32k | $268k | -9% | Dec 2023 |
|
PanAgora Asset Management | 30k | $252k | 100% | Dec 2023 |
|
State of Wisconsin Investment Board | 30k | $246k | 152% | Dec 2023 |
|
Bank of America Corporation | 25k | $206k | 60% | Dec 2023 |
|
Barclays | 25k | $204k | 235% | Dec 2023 |
|
Rhumbline Advisers | 19k | $160k | 3% | Dec 2023 |
|
Exchange Traded Concepts | 19k | $158k | 34% | Dec 2023 |
|
Virtus ETF Advisers | 14k | $118k | 44% | Dec 2023 |
|
California State Teachers Retirement System | 14k | $118k | -9% | Sep 2023 |
|
UBS Group | 13k | $110k | 89% | Dec 2023 |
|
Pale Fire Capital SE | 13k | $105k | 100% | Sep 2023 |
|
Brevan Howard Capital Management | 12k | $99k | 100% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 12k | $97k | 100% | Dec 2023 |
|
XTX Topco | 11k | $96k | 100% | Sep 2023 |
|
Jpmorgan Chase & Co | 9.7k | $81k | -32% | Dec 2023 |
|
Amundi | 9.2k | $107k | 100% | Dec 2023 |
|
American International | 6.6k | $55k | 11% | Dec 2023 |
|
New York State Common Retirement Fund | 6.5k | $54k | -1% | Dec 2023 |
|
Royal Bank of Canada | 5.7k | $48k | -8% | Dec 2023 |
|
Wells Fargo & Company | 4.2k | $35k | 37% | Dec 2023 |
|
NISA Investment Advisors | 3.9k | $32k | 7258% | Dec 2023 |
|
Tower Research Capital | 2.9k | $24k | 15% | Sep 2023 |
|
Citigroup | 1.9k | $16k | 332% | Dec 2023 |
|
Simplex Trading | 1.8k | $15k | 100% | Dec 2023 |
|
Quantbot Technologies | 1.8k | $15k | 100% | Sep 2023 |
|
Legal & General Group | 1.6k | $13k | -89% | Dec 2023 |
|
Amalgamated Bank | 989.00 | $8.0k | -10% | Dec 2023 |
|
Qube Research & Technologies | 936.00 | $7.8k | 100% | Sep 2023 |
|
Summit Investment Advisors | 627.00 | $5.2k | 0% | Dec 2023 |
|
Great-West Life Assurance Company | 569.00 | $5.0k | 0% | Sep 2023 |
|
Group One Trading | 200.00 | $1.7k | 100% | Sep 2023 |
|
Nbc Securities | 150.00 | $1.0k | 0% | Dec 2023 |
|
Russell Investments | 75.00 | $623.002500 | -22% | Dec 2023 |
|
Toronto-Dominion Bank | 34.00 | $283.998600 | 0% | Sep 2023 |
|
Signature | 30.00 | $249.000000 | 0% | Dec 2023 |
|
Us Bancorp | 17.00 | $140.999700 | 0% | Dec 2023 |
|
Farther Finance Advisors | 9.00 | $74.999700 | 100% | Dec 2023 |
|
Pnc Financial Services | 7.00 | $57.999900 | 100% | Dec 2023 |
|
Who sold out of Igm Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Dr. Jeffrey R. Jay, M.D. | Sep 2023 | 615k | $5.1M |
Opaleye Management | Sep 2023 | 261k | $2.2M |
Candriam Luxembourg S.C.A. | Sep 2023 | 175k | $1.5M |
GSA Capital Partners | Sep 2023 | 133k | $1.1M |
Susquehanna International | Jun 2023 | 58k | $536k |
Jacobs Levy Equity Management | Sep 2023 | 56k | $470k |
Swiss National Bank | Sep 2023 | 29k | $239k |
Moore Capital Management | Sep 2023 | 27k | $226k |
Verition Fund Management | Jun 2023 | 17k | $160k |
Engineers Gate Manager | Jun 2023 | 15k | $136k |
Tudor Investment Corporation | Sep 2023 | 15k | $121k |
Prudential Financial | Jun 2023 | 12k | $111k |
Invesco | Jun 2023 | 11k | $104k |
Ubs Global Asset Management Americas | Sep 2023 | 11k | $93k |
Lazard Asset Management | Sep 2023 | 6.3k | $52k |
DekaBank Deutsche Girozentrale | Sep 2023 | 6.3k | $50k |
China Universal Asset Management | Sep 2023 | 837.00 | $7.0k |
Cutler | Sep 2023 | 400.00 | $3.0k |
Lindbrook Capital | Sep 2023 | 150.00 | $1.3k |
Daiwa Securities Group | Sep 2023 | 88.00 | $999.996800 |